TYRATECH, INC. 21 May 2015
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, announces that following its announcement on 9 April 2015, 26,890,413 common shares in the Company on its restricted "TYR" trading line have migrated to its unrestricted trading line "TYRU".
Following the migration of these shares, the Company will continue to have a total of 262,333,111 common shares admitted to AIM (excluding those shares admitted and not allotted under the blocklisting announced on 25 February 2011), of which 138,666,222 will continue to trade under the symbol "TYR" in a restricted manner as permitted by Regulation S of the U.S. Securities Act of 1993 (the "Securities Act") and 123,666,889 will trade under the symbol "TYRU" in an unrestricted manner pursuant to an exemption provided under the Securities Act. CREST settlement will not be available for trades in "TYR" shares. The Company holds 1,084,413 common shares in treasury and these treasury shares are listed on the restricted "TYR" trading line.
For further information please contact:
|
TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer Vincent Morgus, Chief Financial Officer and Treasurer | Tel: +1 919 415 4340 Tel: +1 919 415 4287 |
|
SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44 203 368 3551 Tel: +44 203 368 3552 |
|
Allenby Capital Limited , Joint Broker Chris Crawford | Tel: +44 20 3328 5656 |
|
Whitman Howard Limited, Joint Broker Ranald McGregor-Smith/ Niall Devins | Tel: +44 20 7659 1240 |
|
Walbrook, Financial PR and IR Nick Rome/ Guy McDougall | Tel: +44 20 7933 8790 |
|
distributed by
|
